Brought to you by:
‘Time matters’: New study finds novel EHR workflow improves timeliness in vascular care
A novel, order-initiated workflow facilitated by the electronic health record (EHR) has been shown to improve timeliness of care for vascular surgery patients, decreasing time to operation and working to standardize and automate the consultation process. Presented at the 2023…
Analysis finds no difference in TCAR outcomes between academic, community hospitals
A new study found no difference in perioperative outcomes and incidence of adverse events at follow-up after transcarotid artery revascularization (TCAR) between academic and non-teaching community institutions. Presented at the 2023 winter annual meeting of the Vascular and Endovascular Surgery…
SVS, ACS launch new quality verification program
The Society for Vascular Surgery (SVS) and the American College of Surgeons (ACS) have launched the “Vascular Verification Program (Vascular-VP),” an ACS Quality Program developed in partnership with the SVS. The newly launched inpatient program reviews not just safety processes…
Bioprosthetic venous valve: ‘We want to know that this is really working’
A key investigator in efforts to tackle chronic venous insufficiency (CVI) with an bioprosthetic venous valve replacement talks about progress being made with surgical and endovascular versions of the device—and surgical community skepticism. Jorge Ulloa, MD, has not long since…
Letter to the editor: The vascular influencer
Dear editor, Reading “Likes, dislikes and reposts: The new age of the vascular surgery influencer,” by Drs. Jean Bismuth (@jeanbismuth) and Jonathan Cardella (@yalevascular), they rightly point the spotlight on the trend of some vascular surgeons posting cases on social…
Viz.ai receives FDA 510(k) clearance for abdominal aortic aneurysm AI algorithm
Viz.ai recently announced it has received Food and Drug Administration (FDA) 510(k) clearance for its algorithm intended to detect suspected abdominal aortic aneurysm (AAA). Viz AAA is the first FDA-cleared AI-powered solution for the detection and triage of suspected AAA,…
ABCs for the treatment of lower-extremity acute DVTs
Ashish Gupta, MD, outlines his ABCs for confronting and treating patients with acute deep vein thrombosis (DVT) of the lower extremity, and how he developed his dictums. A is for “anticoagulation” for not more than six months of duration. Rationale:…
From the SVS president: Supporting one another
The Society for Vascular Surgery (SVS) has a vision that is unwavering. We desire quality vascular care for all patients by providing our members with the information and tools they need to provide best care. We believe the goal is…
SCVS 2023: Four decades of AAAs in the US: Rare epidemiological study establishes women are diagnosed and repaired 10 years later than men
Abdominal aortic aneurysm (AAA) diagnosis and repair occurs among women almost 10 years later than in men—with similar age-adjusted mortality—the 2023 Society for Clinical Vascular Surgery (SCVS) annual meeting in Miami (March 25–29) is set to be told. The finding…
Vesteck completes first-in-human use of several Suture-Tight devices
Vesteck scientific advisory board members along with key opinion leaders from around the world have successfully completed the first three in-human cases with the Suture-Tight catheter, a press release reports. Dai Yamanouchi (University of Wisconsin, Madison, USA) and Dainis Krievins…